As It Prepares for a Future with Wyeth, Pfizer Reports Ho-Hum Q1 Results
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer’s first-quarter results were down, but in line with the company’s and Wall Street’s expectations.